A detailed history of Blue Fin Capital, Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Blue Fin Capital, Inc. holds 10,413 shares of BSX stock, worth $952,789. This represents 0.17% of its overall portfolio holdings.

Number of Shares
10,413
Previous 10,007 4.06%
Holding current value
$952,789
Previous $770,000 13.25%
% of portfolio
0.17%
Previous 0.16%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$72.96 - $84.0 $29,621 - $34,104
406 Added 4.06%
10,413 $872,000
Q2 2024

Jul 30, 2024

BUY
$67.33 - $77.71 $95,541 - $110,270
1,419 Added 16.52%
10,007 $770,000
Q1 2024

May 14, 2024

BUY
$57.6 - $68.62 $40,665 - $48,445
706 Added 8.96%
8,588 $588,000
Q4 2023

Feb 06, 2024

SELL
$48.64 - $57.81 $6,906 - $8,209
-142 Reduced 1.77%
7,882 $455,000
Q3 2023

Oct 19, 2023

BUY
$50.19 - $54.68 $66,953 - $72,943
1,334 Added 19.94%
8,024 $423,000
Q3 2022

Nov 04, 2022

SELL
$36.71 - $109.66 $4,478 - $13,378
-122 Reduced 1.79%
6,690 $259,000
Q1 2022

Apr 12, 2022

SELL
$40.9 - $45.1 $2,249 - $2,480
-55 Reduced 0.8%
6,812 $301,000
Q4 2021

Jan 19, 2022

SELL
$38.07 - $44.87 $6,509 - $7,672
-171 Reduced 2.43%
6,867 $291,000
Q3 2021

Oct 25, 2021

SELL
$41.23 - $45.88 $13,028 - $14,498
-316 Reduced 4.3%
7,038 $305,000
Q2 2021

Jul 19, 2021

SELL
$38.58 - $44.24 $12,384 - $14,201
-321 Reduced 4.18%
7,354 $314,000
Q1 2021

May 05, 2021

SELL
$35.27 - $39.67 $14,883 - $16,740
-422 Reduced 5.21%
7,675 $296,000
Q4 2020

Jan 28, 2021

SELL
$33.15 - $41.97 $22,276 - $28,203
-672 Reduced 7.66%
8,097 $291,000
Q3 2020

Oct 28, 2020

BUY
$34.44 - $42.23 $22,764 - $27,914
661 Added 8.15%
8,769 $335,000
Q2 2020

Aug 10, 2020

BUY
$30.19 - $39.11 $19,502 - $25,265
646 Added 8.66%
8,108 $284,000
Q1 2020

Apr 28, 2020

BUY
$25.83 - $45.71 $7,748 - $13,713
300 Added 4.19%
7,462 $243,000
Q4 2019

Feb 10, 2020

BUY
$37.87 - $45.37 $24,842 - $29,762
656 Added 10.08%
7,162 $322,000
Q3 2019

Nov 07, 2019

SELL
$40.31 - $43.45 $11,206 - $12,079
-278 Reduced 4.1%
6,506 $264,000
Q2 2019

Jul 22, 2019

BUY
$34.91 - $42.98 $15,046 - $18,524
431 Added 6.78%
6,784 $291,000
Q1 2019

Apr 23, 2019

BUY
$32.91 - $40.75 $209,077 - $258,884
6,353 New
6,353 $243,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $131B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Blue Fin Capital, Inc. Portfolio

Follow Blue Fin Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Fin Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Fin Capital, Inc. with notifications on news.